Sandmaier, B. M., Kornblit, B., Storer, B. E., Olesen, G., Maris, M. B., Langston, A. A., Gutman, J. A., Petersen, S. L., Chauncey, T. R., Bethge, W. A., Pulsipher, M. A., Woolfrey, A. E., Mielcarek, M., Martin, P. J., Appelbaum, F. R., Flowers, M. E. D., Maloney, D. G., & Storb, R. (2019). addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. Lancet, 6(8), e409–e418. http://access.bl.uk/ark:/81055/vdc_100088833304.0x000007